BioHarvest Sciences Other Non-Current Liabilities 2020-2024 | BHST
BioHarvest Sciences other non-current liabilities from 2020 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
BioHarvest Sciences Annual Other Non-Current Liabilities (Millions of US $) |
2023 |
$2 |
2022 |
$2 |
2021 |
$2 |
2020 |
$3 |
2019 |
$2 |
2019 |
$2 |
2018 |
$ |
BioHarvest Sciences Quarterly Other Non-Current Liabilities (Millions of US $) |
2024-06-30 |
$2 |
2024-03-31 |
$2 |
2023-12-31 |
$2 |
2023-09-30 |
$2 |
2023-06-30 |
$2 |
2023-03-31 |
$2 |
2022-12-31 |
$2 |
2022-09-30 |
$2 |
2022-06-30 |
$2 |
2022-03-31 |
$2 |
2021-12-31 |
$2 |
2021-09-30 |
$4 |
2021-06-30 |
$4 |
2021-03-31 |
$3 |
2020-12-31 |
$3 |
2020-09-30 |
$3 |
2020-06-30 |
$2 |
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
$2 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|